Your browser doesn't support javascript.
loading
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.
Ruigómez, Ana; Schink, Tania; Voss, Annemarie; Herings, Ron M C; Smits, Elisabeth; Swart-Polinder, Karin; Balabanova, Yanina; Brobert, Gunnar; Suzart-Woischnik, Kiliana; García Rodríguez, Luis Alberto.
Afiliação
  • Ruigómez A; Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain.
  • Schink T; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
  • Voss A; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
  • Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
  • Smits E; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
  • Swart-Polinder K; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
  • Balabanova Y; Bayer AG, Berlin, Germany.
  • Brobert G; Bayer AB, Stockholm, Sweden.
  • Suzart-Woischnik K; Bayer AG, Berlin, Germany.
  • García Rodríguez LA; Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain.
PLoS One ; 19(3): e0298596, 2024.
Article em En | MEDLINE | ID: mdl-38451960
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tromboembolia Venosa Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tromboembolia Venosa Idioma: En Ano de publicação: 2024 Tipo de documento: Article